Rapid Decline in Folylpolyglutamate Synthetase Activity and Gene Expression during Maturation of HL-60 Cells

These studies in HL-60 cells examined the regulation of folylpolyglutamate synthetase (FPGS) activity at the level of gene expression during terminal maturation. Following addition of 210 mM Me2SO to cultures of HL-60 cells at a concentration that induces maturation of 85-90% of the cells, FPGS activity, but not folylpolyglutamate hydrolase (FPGH) activity, was reduced 2-7-fold within 1-5 days. The initial decline in FPGS activity preceded any effect of Me2SO on rate of growth and the increase in appearance of nitro blue tetrazoliumpositive cells, a marker of cellular maturation, and the decrease after 5 days of exposure to Me2SO was solely accounted for by a 7-fold decrease in value for Vmax. The same time and concentration dependence for Me2SO was shown for the decline in FPGS activity, increase in nitro blue tetrazolium-positive cells, and decline in the level of a 2.1-kilobase FPGS mRNA during exposure to this inducer. This decline in FPGS mRNA was reversible when Me2SO was removed from the culture medium but only until that time when an appreciable number of cells were committed to terminal maturation. Following growth of HL-60 cells with [3H]MTX, used as a model folate compound, a large reduction in its intracellular polyglutamate pools was shown during maturation which quantitatively reflected the decline in FPGS activity as well as folate transport inward (Sirotnak, F. M., Jacobson, D. M., and Yang, C-H.(1986) J. Biol. Chem. 261, 11150-11156). Other data showed that folate status or obviation of the folate requirement during growth of these cells strongly influenced the rapidity of the onset of maturation following exposure to inducer. Overall, these results show that FPGS activity in HL-60 cells is a marker for proliferative capacity and that the underlying basis for the decline in FPGS activity during maturation is altered cognate gene expression which is manifested as early reversible and late irreversible phases. They also suggest that the coordinate reduction observed in folate transport, FPGS activity, dihydrofolate reductase, and probably other folate related enzymes by limiting macromolecular biosynthesis may be early programmed events in the maturation process that influence the switch from proliferation to senescence in these cells.

[1]  A. Bloch.  Dynamics of interaction between DNA-specific antitumor agents and serum-contained cytokines in the initiation of ML-1 human myeloblastic leukemia cell differentiation. , 1993, Leukemia.

[2]  Ying Wang,et al.  Acquisition of Resistance to Antifolates Caused by Enhanced γ-Glutamyl Hydrolase Activity , 1993 .

[3]  J. Barredo,et al.  Determinants of antifolate cytotoxicity: folylpolyglutamate synthetase activity during cellular proliferation and development. , 1992, Molecular pharmacology.

[4]  A. Admon,et al.  Expression cloning of a human cDNA encoding folylpoly(gamma-glutamate) synthetase and determination of its primary structure. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[5]  F. Sirotnak,et al.  Metabolic turnover of methotrexate polyglutamates in lysosomes derived from S180 cells. Definition of a two-step process limited by mediated lysosomal permeation of polyglutamates and activating reduced sulfhydryl compounds. , 1992, The Journal of biological chemistry.

[6]  F. Sirotnak,et al.  Alteration of folate analogue transport inward after induced maturation of HL-60 leukemia cells. Molecular properties of the transporter in an overproducing variant and evidence for down-regulation of its synthesis in maturating cells. , 1992, The Journal of biological chemistry.

[7]  J. C. Schmitz,et al.  Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously. , 1991, Journal of the National Cancer Institute.

[8]  J. Bertino,et al.  Decreased folylpolyglutamate synthetase activity as a mechanism of methotrexate resistance in CCRF-CEM human leukemia sublines. , 1991, The Journal of biological chemistry.

[9]  B. Rumberger,et al.  Differing specificities for 4-aminofolate analogues of folylpolyglutamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action. , 1990, Cancer research.

[10]  F. Sirotnak,et al.  Proliferation-dependency of folylpolyglutamyl synthetase activity in maturating luminal epithelial cells of mouse small intestine. , 1988, Biochemical pharmacology.

[11]  J. Frelinger,et al.  A simple, rapid method for the purification of poly A+ RNA. , 1988, BioTechniques.

[12]  F. Sirotnak,et al.  Alteration of folate analogue transport following induced maturation of HL-60 leukemia cells. Early decline in mediated influx, relationship to commitment, and functional dissociation of entry and exit routes. , 1986, The Journal of biological chemistry.

[13]  F. Sirotnak,et al.  Hydrolytic cleavage of methotrexate gamma-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse. , 1986, Cancer research.

[14]  F. Sirotnak.  Obligate genetic expression in tumor cells of a fetal membrane property mediating "folate" transport: biological significance and implications for improved therapy of human cancer. , 1985, Cancer research.

[15]  F. Sirotnak,et al.  Similar differential for total polyglutamylation and cytotoxicity among various folate analogues in human and murine tumor cells in vitro. , 1985, Cancer research.

[16]  R. Moran,et al.  Mammalian folyl polyglutamate synthetase: partial purification and properties of the mouse liver enzyme. , 1984, Biochemistry.

[17]  I. Goldman,et al.  Polyglutamylation, an important element in methotrexate cytotoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro. , 1984, Cancer research.

[18]  M. Sonenberg,et al.  Transport of the folate compound methotrexate decreases during differentiation of murine erythroleukemia cells. , 1984, The Journal of biological chemistry.

[19]  H. Blau,et al.  Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed , 1983, Molecular and cellular biology.

[20]  F. Sirotnak,et al.  Further studies stereospecificity at carbon 6 for membrane transport of tetrahydrofolates. Diastereoisomers of 5-methyltetrahydrofolates as competitive inhibitors of transport of methotrexate in L1210 cells. , 1982, Biochemical pharmacology.

[21]  D. Fujimoto,et al.  Increased histone acetylation and deacetylation in rat ascites hepatoma cells. , 1981, Cancer research.

[22]  P. Thomas,et al.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Collins,et al.  Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia , 1979 .

[24]  M. McBurney,et al.  Isolation and biochemical characterization of folate deficient mutants of Chinese hamster cells. , 1974, Cell.

[25]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[26]  B. Shane.  Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. , 1989, Vitamins and hormones.

[27]  R. Moran,et al.  Structural features of 4-amino antifolates required for substrate activity with mammalian folylpolyglutamate synthetase. , 1985, Molecular pharmacology.

[28]  G. L. Peterson.  [12] Determination of total protein , 1983 .